featured
FDA Approves Praluent to Treat Certain Patients With High Cholesterol
First in a new class of injectable cholesterol-lowering drugs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: